Needham & Company reiterates a 'Buy' on Aegerion Pharmaceuticals (NASDAQ: AEGR) price target of $23.00 (from $24.00).

Analyst, Chad ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE